ImmuneBridge
Blood & Organ Banks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2122 Bryant St, San Francisco, Californi...Phone Number
(415) 624-6411Website
www.immunebridge.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
2
3
5
3
About ImmuneBridge
ImmuneBridge specializes in developing high-quality cell therapies using umbilical cord blood stem cells, leveraging advanced machine learning for efficient donor screening and scalable manufacturing. Their proprietary technology aims to address key challenges in cell therapy, such as high costs and poor manufacturability, ensuring safe and effective treatments for patients. The company collaborates with partners in academia and industry to create innovative therapies for previously untreatable diseases. ImmuneBridge is committed to making cell therapies accessible and affordable on a global scale.Explore more
ImmuneBridge Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ImmuneBridge your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ImmuneBridge has new funding data
Click to see if ImmuneBridge had a recent Job posting/layoffs
Check out if ImmuneBridge is spiking on competitors!
Product Launch: Get notified when ImmuneBridge launches new products
ImmuneBridge, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ImmuneBridge has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at ImmuneBridge
Earning: See what the market has to say on ImmuneBridge recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ImmuneBridge
Compare insights from companies similar to ImmuneBridge, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ImmuneBridge is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
ImmuneBridge is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about ImmuneBridge.
ImmuneBridge financials insights
Gather financial insights about ImmuneBridge, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$12M
ImmuneBridge Tech Stack
A closer look at the technologies used by ImmuneBridge
ImmuneBridge News & Media
ImmuneBridge Raises $12M from M Ventures and Insight Partners to Advance Novel Natural Killer (NK) Cell-based Immunotherapies
SAN FRANCISCO--(BUSINESS WIRE)-- #NKcells--ImmuneBridge announces seed financing co-led by Insight Partners and M Ventures.
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ImmuneBridge
Sign Up For FreeTo access detailed company insights
ImmuneBridge specializes in developing high-quality cell therapies using umbilical cord blood stem cells, leveraging advanced machine learning for efficient donor screening and scalable manufacturing. Their proprietary technology aims to address key challenges in cell therapy, such as high costs and poor manufacturability, ensuring safe and effecti... Read More
